EXCLUSIVE LICENSE AND COLLABORATION AGREEMENTExclusive License and Collaboration Agreement • May 11th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
THIS EXCLUSIVE AND COLLABORATION LICENSE AGREEMENT (this “Agreement”) dated as of April 16, 2014 (the “Effective Date”), is entered into between Sentinel Oncology Limited (“Licensor”), having a place of business at 23 Cambridge Science Park, Milton Road, Cambridge, United Kingdom CB4 0EY, and Oncothyreon Inc., a Delaware corporation (“Company”), having a place of business at 2601 Fourth Ave., Suite 500, Seattle, WA 98121, USA, each a “Party” and collectively “Parties”.
FIRST AMENDMENT TO PATENT LICENSE AGREEMENT between STC.UNM and ONCOTHYREON INC.Patent License Agreement • May 11th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research
THIS FIRST AMENDMENT TO PATENT LICENSE AGREEMENT (“First Amendment”) is made as of February 2, 2015 (the “First Amendment Effective Date”) by and between STC.UNM (hereinafter referred to as “STC”), a New Mexico nonprofit corporation, with its principal office at 801 University Boulevard SE, Suite 101, Albuquerque, New Mexico 87106, and ONCOTHYREON INC. (hereinafter referred to as “Oncothyreon”), a Delaware corporation with a principal office at 2601 Fourth Avenue, Suite 500, Seattle, WA 98121. As of the First Amendment Effective Date, in consideration of the mutual covenants and promises herein contained, the parties agree as follows:
